Acquisition - Pro Forma Results (Details) - Zoetis Inc Medicated Feed Additive Product Portfolio - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024
Business acquisition, pro forma information
Net sales	$ 347,825	$ 354,252	$ 1,067,875	$ 1,043,063
Operating income	$ 33,515	$ 38,697	$ 120,145	$ 79,221

The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Name:	us-gaap_BusinessAcquisitionsProFormaRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration